Arrowhead Pharma Earnings Estimates, EPS & Revenue | NASDAQ:ARWR

Comments

Arrowhead Pharmaceuticals Inc Earnings Estimates

ARWRNASDAQ

Trade with Public

$64.36

3.185.20%

At close: Apr 8, 5:00 PM EST

$64.36

N/A

After Hours: 4:00 PM EST

Overview NewsEarningsOptions Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Arrowhead Pharma Earnings Estimates, EPS & Revenue | NASDAQ:ARWR

Arrowhead Pharma (ARWR) is scheduled to report Q2 earnings on May 11, 2026. Analysts estimate EPS of $-1.02 and quarterly revenue of $79.72M.

In the most recent quarter (Q1), Arrowhead Pharma reported EPS of $0.22, beating estimates of $0.02 by 10.00%. Revenue came in at $264.03M, exceeding the estimate of $256.62M by 0.03%.

Over the last 4 quarters, Arrowhead Pharma has averaged an EPS surprise of 4.95% and a revenue surprise of 1.08%.

Earnings Date

May 11

EPS Estimate

$-1.020

Quarterly Revenue Estimate

$79.72M

Annual Revenue
(as of Dec 31)

$1.09B

Arrowhead Pharma Earnings History

Analyze the earnings history of Arrowhead Pharma using advanced sorting and filters.

Loading calendar...

Arrowhead Pharma (ARWR) Earnings Per Share

The chart below shows Arrowhead Pharma's reported EPS compared to analyst estimates over recent quarters.

Arrowhead Pharma (ARWR) Revenue

The chart below shows Arrowhead Pharma's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Arrowhead Pharma (NASDAQ:ARWR) reporting earnings?

Arrowhead Pharma (ARWR) is scheduled to report earnings on May 11, 2026. The last reported earnings were for reported on February 5, 2026 for Q1.

What were the latest earnings per share (EPS) for Arrowhead Pharma (NASDAQ:ARWR)?

The Actual EPS was $0.22, which beat the estimate of $0.02.

What were Arrowhead Pharma’s (NASDAQ:ARWR) revenues?

The Actual Revenue was $264.03M, which beat the estimate of $256.62M.

People Also Watch

Cogent Biosciences Inc

NASDAQ:COGT

$37.03

0.95%

Neurocrine Biosciences Inc

NASDAQ:NBIX

$131.20

-1.08%

Centessa Pharmaceuticals PLC

NASDAQ:CNTA

$39.70

0.63%

Ionis Pharmaceuticals Inc

Protagonist Therapeutics Inc

NASDAQ:PTGX

$103.82

0.97%

Apogee Therapeutics Inc

NASDAQ:APGE

$85.06

2.77%

Madrigal Pharmaceuticals Inc

NASDAQ:MDGL

$520.00

0.50%

Arrowhead Pharma Earnings Estimates, EPS & Revenue | NASDAQ:ARWR

Arrowhead Pharma (ARWR) is scheduled to report Q2 earnings on May 11, 2026. Analysts estimate EPS of $-1.02 and quarterly revenue of $79.72M.

In the most recent quarter (Q1), Arrowhead Pharma reported EPS of $0.22, beating estimates of $0.02 by 10.00%. Revenue came in at $264.03M, exceeding the estimate of $256.62M by 0.03%.

Over the last 4 quarters, Arrowhead Pharma has averaged an EPS surprise of 4.95% and a revenue surprise of 1.08%.

Earnings Date

May 11

EPS Estimate

$-1.020

Quarterly Revenue Estimate

$79.72M

Annual Revenue
(as of Dec 31)

$1.09B